E
Bionano Genomics, Inc. BNGO
$3.91 $0.07451.94% NASDAQ
Recommendation
Prev Close
$3.84
Volume
70,601
Avg Vol (90D)
205,883
Market Cap
$11.53M
Dividend & Yield
--
52-Week Range
$2.68 - $72.60
P/E (TTM)
--
EPS (TTM)
-$93.54
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Bionano to Report First Quarter 2025 Financial Results and Host a Conference Call Webcast on May 14, 2025
5/7/2025 - Globe Newswire
International Consortium for Optical Genome Mapping Publishes Expert Recommendations for Integration of OGM as a Standard-of-Care Cytogenetic Assay for Diagnostic Workflows in Blood Cancers
5/2/2025 - Globe Newswire
Bionano Genomics (BNGO) Highlights Optical Genome Mapping in Detecting Genetic Disorders BNGO ...
4/23/2025 - GuruFocus
Bionano Genomics announces publication on OGM
4/23/2025 - The Fly
Bionano Announces Publication Showing OGM can Provide an Accurate and Cost-Effective Solution for Sizing Large Repeat Expansions in Constitutional Genetic Disease
4/23/2025 - Globe Newswire
Bionano Genomics (BNGO) Projects Stable Revenue Growth for 2025
4/10/2025 - GuruFocus
Bionano Genomics (BNGO) Faces Revenue Growth, Missed EPS Targets
4/10/2025 - GuruFocus
Bionano Genomics (BNGO) Advances Multiple Myeloma Analysis
4/10/2025 - GuruFocus
Bionano Genomics (BNGO) Sees Revenue Upgrade Despite Lower Price Target
4/10/2025 - GuruFocus
Bionano Genomics (BNGO) Reports Q4 2024 Earnings: Revenue Decline but Margin Improvement
4/10/2025 - GuruFocus
Bionano Genomics initiated with bullish view at H.C. Wainwright, here's why
4/9/2025 - The Fly
Bionano Announces French Publication of an Effective Method for Analysis of Multiple Myeloma by OGM
4/8/2025 - Globe Newswire
Revenues Working Against Bionano Genomics, Inc.'s (NASDAQ:BNGO) Share Price Following 26% Dive
4/5/2025 - Simply Wall St
Bionano Genomics Inc Reports Q4 Revenue of $8.2 Million, Surpassing Estimates
4/2/2025 - GuruFocus
Bionano Genomics (NASDAQ:BNGO) Given New $4.00 Price Target at Scotiabank
4/2/2025 - Ticker Report
Bionano Genomics price target raised by $3 at Scotiabank, here's why
4/2/2025 - The Fly
Bionano Genomics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
4/2/2025 - Simply Wall St
Bionano Genomics Q4 Earnings Call: Mixed Sentiments and Strategic Shifts
4/2/2025 - TipRanks Financial Blog
Bionano Genomics Inc (BNGO) Q4 2024 Earnings Call Highlights: Strategic Cost Reductions and ...
4/1/2025 - GuruFocus
Q4 2024 Bionano Genomics Inc Earnings Call Transcript
4/1/2025 - GuruFocus
Bionano Genomics (BNGO) Projects Growth in 2025 Amid Strategic Focus
4/1/2025 - GuruFocus
Bionano Genomics (BNGO) Q4 2024 Earnings Call Transcript
4/1/2025 - Fool.com Headlines
Bionano Genomics outlines 2025 revenue guidance of $29M-$32M with strategic focus on utilization
4/1/2025 - SeekingAlpha.com: All News
Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript
4/1/2025 - SeekingAlpha
Bionano Genomics, Inc. (BNGO) Q4 2024 Earnings Call Transcript
4/1/2025 - Seeking Alpha: Transcripts
Income Statement
Total Revenue (TTM)
$30.78M
EBITDA (TTM)
-$52.00M
EBIT (TTM)
-$66.03M
Net Income (TTM)
-$112.02M
Balance Sheet
Total Assets (Q)
$76.67M
Total Debt (Q)
$27.30M
Total Liabilities (Q)
$41.30M
Book Value Per Share (Q)
$18.96
Cash Flow
Cash from Operations (TTM)
-$68.92M
Cash from Investing (TTM)
$73.84M
Cash from Financing (TTM)
-$13.69M
Net Change in Cash (TTM)
-$8.78M
Filings
Filing Date
Monday, March 31, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.63
7-Day Total Return
-2.25%
30-Day Total Return
34.83%
60-Day Total Return
-29.29%
90-Day Total Return
-77.22%
Year to Date Total Return
-74.47%
1-Year Total Return
-93.18%
2-Year Total Return
-99.16%
3-Year Total Return
-99.54%
5-Year Total Return
-98.52%
52-week Low
Mar 31, 2025 - $2.68
52-week High
May 15, 2024 - $72.60
Valuation
Market Cap
$11.53M - Nano Cap
Enterprise Value
$29.36M
Price/Sales (TTM)
0.21
Price/Book (Q)
0.20
Dividends and Shares
Shares Outstanding
1.65M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.bionano.com
Phone Number
858 888 7600
Address
9540 Towne Centre Drive
San Diego, CA 92121
Country
United States
Year Founded
2003
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Bionano Genomics, Inc. provides genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for... more
NASDAQ 05/12/2025 4:00PM Eastern Quotes delayed